[go: up one dir, main page]

IS4446A - Andestrogen benzothiophenyl efnasambönd - Google Patents

Andestrogen benzothiophenyl efnasambönd

Info

Publication number
IS4446A
IS4446A IS4446A IS4446A IS4446A IS 4446 A IS4446 A IS 4446A IS 4446 A IS4446 A IS 4446A IS 4446 A IS4446 A IS 4446A IS 4446 A IS4446 A IS 4446A
Authority
IS
Iceland
Prior art keywords
androgenic
benzothiophenyl
compounds
benzothiophenyl compounds
androgenic benzothiophenyl
Prior art date
Application number
IS4446A
Other languages
English (en)
Other versions
IS1788B (is
Inventor
Smith Labell Elisabeth
Douglas Luke Wayne
Mcneill Mcgill John
Scot Miller Randal
Original Assignee
Eli Lilly And Company, Patent Division
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS4446(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/308,325 external-priority patent/US5629425A/en
Application filed by Eli Lilly And Company, Patent Division filed Critical Eli Lilly And Company, Patent Division
Publication of IS4446A publication Critical patent/IS4446A/is
Publication of IS1788B publication Critical patent/IS1788B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS4446A 1994-09-19 1997-03-18 Andestrogen benzothiophenyl efnasambönd IS1788B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/308,325 US5629425A (en) 1994-09-19 1994-09-19 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A 1995-04-26 1995-04-26
PCT/US1995/011872 WO1996009045A1 (en) 1994-09-19 1995-09-19 Antiestrogenic benzothiophenyl compounds

Publications (2)

Publication Number Publication Date
IS4446A true IS4446A (is) 1997-03-18
IS1788B IS1788B (is) 2001-11-28

Family

ID=26976194

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4446A IS1788B (is) 1994-09-19 1997-03-18 Andestrogen benzothiophenyl efnasambönd

Country Status (50)

Country Link
US (4) US5731327A (is)
JP (2) JP2860071B2 (is)
KR (2) KR100381346B1 (is)
CN (2) CN1068324C (is)
AP (1) AP754A (is)
AT (2) AT407988B (is)
AU (3) AU692907B2 (is)
BE (2) BE1009626A3 (is)
BG (1) BG62793B1 (is)
BR (2) BR9504059A (is)
CA (2) CA2158399C (is)
CH (3) CH691125A5 (is)
CO (2) CO4410190A1 (is)
CZ (2) CZ292007B6 (is)
DE (3) DE19534744A1 (is)
DK (4) DK175897B1 (is)
EE (1) EE03386B1 (is)
EG (1) EG23763A (is)
ES (2) ES2129293B1 (is)
FI (2) FI121424B (is)
FR (2) FR2732020B1 (is)
GB (2) GB2293382B (is)
GE (1) GEP19991821B (is)
GR (2) GR1002697B (is)
HR (2) HRP950483B1 (is)
HU (2) HU227683B1 (is)
IE (2) IE950722A1 (is)
IL (3) IL115315A (is)
IS (1) IS1788B (is)
IT (2) IT1277601B1 (is)
LU (2) LU88661A1 (is)
LV (2) LV11177B (is)
MY (1) MY116371A (is)
NL (2) NL1001194C2 (is)
NO (2) NO308107B1 (is)
NZ (2) NZ280027A (is)
OA (1) OA10406A (is)
PE (2) PE14796A1 (is)
PL (2) PL182450B1 (is)
PT (2) PT101770B (is)
RO (2) RO115260B1 (is)
RS (2) RS49578B (is)
SE (2) SE509265C2 (is)
SI (2) SI9500292A (is)
SK (1) SK283502B6 (is)
TR (1) TR199501136A2 (is)
TW (1) TW412534B (is)
UA (2) UA44240C2 (is)
UY (1) UY24040A1 (is)
WO (1) WO1996009045A1 (is)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410190A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
AU723797B2 (en) * 1996-03-26 2000-09-07 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
RU2203060C2 (ru) 1996-10-30 2003-04-27 Эли Лилли Энд Компани Способ профилактики рака молочной железы
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
CN1250563C (zh) 1999-05-04 2006-04-12 斯特拉坎有限公司 雄激素糖苷及其产生雄性征的活性
US6921827B2 (en) * 2000-11-27 2005-07-26 Eli Lilly And Company Process for preparing 3-aryl-benzo{b} thiophenes
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
ATE541840T1 (de) 2002-09-30 2012-02-15 Gea Farmaceutisk Fabrik As Raloxifene-l-lactat oder ein hemihydrat davon, deren verwendungen, pharmazeutischen zusammensetzungen und herstellungsverfahren
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de) 2004-06-24 2006-01-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PT1797038E (pt) 2004-09-29 2012-08-14 Bayer Pharma AG Forma termodinamicamente estável de tosilato de bay 43-9006
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
GB2456096B (en) * 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
US8258291B2 (en) * 2006-10-25 2012-09-04 Mamtek International Limited Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
US20080103295A1 (en) * 2006-10-25 2008-05-01 David Losan Ho Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
DE102007032451B4 (de) 2007-07-12 2010-09-30 Icfs Gmbh Verfahren zur Herstellung von aromatischen Ketonen
WO2009015004A1 (en) * 2007-07-20 2009-01-29 King Pharmaceuticals Research And Development, Inc. Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone
CA2695406A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
WO2009080364A1 (en) * 2007-12-21 2009-07-02 Synthon B.V. Raloxifene composition
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US20110088613A1 (en) * 2008-06-09 2011-04-21 Massimo Ferrari Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
MX2011006713A (es) 2008-12-23 2011-07-13 Boehringer Ingelheim Int Formas salinas de compuesto organico.
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP2448562B1 (en) 2009-07-02 2013-11-06 Synthon B.V. Raloxifene composition
EP2314581B1 (en) 2009-10-23 2012-07-25 Hexal AG A process for preparing benzo[b]thiophene derivatives
PH12012501037A1 (en) 2009-11-27 2013-01-14 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
JP6034781B2 (ja) 2010-05-05 2016-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 併用療法
KR20130093012A (ko) 2010-06-24 2013-08-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) * 2010-10-25 2013-10-04 Fidia Farmaceutici Nuova forma polimorfa di raloxifene cloridrato
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
DK3517539T3 (en) 2011-07-15 2023-01-16 Boehringer Ingelheim Int Farmaceutiske sammensætninger til behandling af type i og type ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
IN2013MU00665A (is) 2013-03-05 2015-07-03 Cipla Ltd
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｄｐｐ−４阻害薬の医学的使用
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) * 2014-12-02 2015-04-08 千辉药业（安徽）有限责任公司 一种盐酸雷洛昔芬的制备方法
JP2019517542A (ja) 2016-06-10 2019-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング リナグリプチンおよびメトホルミンの組合せ
KR102815172B1 (ko) * 2020-02-25 2025-05-29 엘지전자 주식회사 히트펌프 및 그 동작방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869485A (en) * 1969-09-25 1975-03-04 Allied Chem Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
ZA822247B (en) 1981-04-03 1983-11-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
GB2097788B (en) * 1981-04-03 1985-04-24 Lilly Co Eli Benzothiophene compounds and process for preparing them
IL65379A0 (en) 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
IL65378A (en) * 1981-04-03 1986-02-28 Lilly Co Eli Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
US4358593A (en) * 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5169860A (en) 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
CZ285522B6 (cs) 1993-06-24 1999-08-11 Eli Lilly And Company Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5523416A (en) 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410190A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO

Also Published As

Publication number Publication date
UA44240C2 (uk) 2002-02-15
GR1002697B (el) 1997-05-22
BG101242A (en) 1998-03-31
AU691955B2 (en) 1998-05-28
LV11177B (en) 1996-08-20
DK102795A (da) 1996-03-20
RS49513B (sr) 2006-10-27
FI954402A0 (fi) 1995-09-18
JP2860071B2 (ja) 1999-02-24
CN1132205A (zh) 1996-10-02
CO4410191A1 (es) 1997-01-09
FI121424B (fi) 2010-11-15
EG23763A (en) 2007-08-08
IS1788B (is) 2001-11-28
GB9519028D0 (en) 1995-11-15
GR1002709B (el) 1997-06-04
US6472531B1 (en) 2002-10-29
AP754A (en) 1999-07-22
JPH08193081A (ja) 1996-07-30
GB2293602B (en) 1998-05-06
ES2129293B1 (es) 2000-01-16
SE520721C2 (sv) 2003-08-12
DE19534744A1 (de) 1996-03-21
KR960010634A (ko) 1996-04-20
MY116371A (en) 2004-01-31
ES2109882B1 (es) 1998-08-16
HU225417B1 (en) 2006-11-28
PE32796A1 (es) 1996-08-07
FR2732020B1 (fr) 1997-11-14
SE9503214D0 (sv) 1995-09-15
DK175897B1 (da) 2005-05-30
NO953657D0 (no) 1995-09-15
FR2724655A1 (fr) 1996-03-22
IE950722A1 (en) 1996-03-20
BR9504059A (pt) 1996-09-24
IL125283A (en) 2001-06-14
BG62793B1 (bg) 2000-08-31
NL1001194A1 (nl) 1996-03-19
ITMI951936A1 (it) 1997-03-15
GB9519032D0 (en) 1995-11-15
US20020173645A1 (en) 2002-11-21
IT1277602B1 (it) 1997-11-11
HK1019009A1 (en) 2000-01-14
CZ240295A3 (en) 1996-04-17
PL310517A1 (en) 1996-04-01
GB2293382B (en) 1998-08-19
IT1277601B1 (it) 1997-11-11
SE9503213D0 (sv) 1995-09-15
IL115315A (en) 1999-09-22
TR199501136A2 (tr) 1996-06-21
DK175903B1 (da) 2005-06-06
HRP950483B1 (en) 2003-02-28
GEP19991821B (en) 1999-11-05
HRP950483A2 (en) 1997-10-31
AP9700938A0 (en) 1997-04-30
FI112226B (fi) 2003-11-14
SI9500293A (en) 1996-06-30
PL187686B1 (pl) 2004-09-30
HU9502721D0 (en) 1995-11-28
AT502957A1 (de) 2007-06-15
KR960010637A (ko) 1996-04-20
FI954403A7 (fi) 1996-03-20
BR9504060A (pt) 1996-09-24
GB2293382A (en) 1996-03-27
NO308107B1 (no) 2000-07-24
CH691478A5 (de) 2001-07-31
SE509265C2 (sv) 1998-12-21
RO115260B1 (ro) 1999-12-30
DK2797A (da) 1997-01-09
CH691594A5 (de) 2001-08-31
HRP950482B1 (en) 2007-04-30
FR2724655B1 (fr) 1997-11-14
AU3718695A (en) 1996-04-09
CA2158399C (en) 2001-03-20
OA10406A (en) 2001-12-05
PT101770B (pt) 1997-04-30
SE9503213L (sv) 1996-03-20
LV11178A (lv) 1996-04-20
CH691125A5 (de) 2001-04-30
CA2158400C (en) 2006-10-24
NZ280028A (en) 1997-05-26
NO313996B1 (no) 2003-01-13
EE03386B1 (et) 2001-04-16
DK102895A (da) 1996-03-20
ITMI951936A0 (it) 1995-09-15
BE1009626A3 (fr) 1997-06-03
CN1127253A (zh) 1996-07-24
CA2158400A1 (en) 1996-03-20
DK175887B1 (da) 2005-05-23
FI954402L (fi) 1996-03-20
FR2732020A1 (fr) 1996-09-27
LV11178B (en) 1996-08-20
BE1009625A3 (fr) 1997-06-03
LV11177A (lv) 1996-04-20
DE19549755B4 (de) 2005-05-04
PT101770A (pt) 1996-04-30
PL310518A1 (en) 1996-04-01
CN1075069C (zh) 2001-11-21
CO4410190A1 (es) 1997-01-09
PT101771A (pt) 1996-04-30
HU9502723D0 (en) 1995-11-28
FI954403A0 (fi) 1995-09-18
WO1996009045A1 (en) 1996-03-28
IE80883B1 (en) 1999-05-19
IL115314A (en) 2000-02-29
CN1068324C (zh) 2001-07-11
NO953658L (no) 1996-03-20
AU692907B2 (en) 1998-06-18
AT407988B (de) 2001-07-25
UA42716C2 (uk) 2001-11-15
YU61395A (sh) 1998-09-18
EE9700055A (et) 1997-08-15
NZ280027A (en) 1997-05-26
JPH08176147A (ja) 1996-07-09
SI9500292A (en) 1996-06-30
SK23397A3 (en) 1997-08-06
ATA154295A (de) 2000-12-15
HUT75033A (en) 1997-03-28
ES2109882A1 (es) 1998-01-16
NL1001194C2 (nl) 1997-04-04
NO953658D0 (no) 1995-09-15
RO115259B1 (ro) 1999-12-30
US6399778B1 (en) 2002-06-04
IL115315A0 (en) 1995-12-31
CZ292007B6 (cs) 2003-07-16
LU88660A1 (fr) 1996-07-15
CZ290343B6 (cs) 2002-07-17
US5731327A (en) 1998-03-24
IL115314A0 (en) 1996-05-14
PE14796A1 (es) 1996-05-19
ITMI951935A1 (it) 1997-03-15
CA2158399A1 (en) 1996-03-20
DK2897A (da) 1997-01-09
ITMI951935A0 (it) 1995-09-15
HUT74178A (en) 1996-11-28
SE9503214L (sv) 1996-03-20
PL182450B1 (pl) 2002-01-31
TW412534B (en) 2000-11-21
NO953657L (no) 1996-03-20
GB2293602A (en) 1996-04-03
PT101771B (pt) 1997-04-30
NL1001196A1 (nl) 1996-03-19
KR100367376B1 (ko) 2003-03-06
YU61495A (sh) 1998-05-15
KR100381346B1 (ko) 2004-04-13
DK175886B1 (da) 2005-05-23
HRP950482A2 (en) 1998-02-28
DE19534745A1 (de) 1996-04-04
AU3173195A (en) 1996-04-04
UY24040A1 (es) 1996-03-07
SK283502B6 (sk) 2003-08-05
CZ240395A3 (en) 1996-04-17
HU227683B1 (en) 2011-11-28
IE950721A1 (en) 1996-03-20
LU88661A1 (fr) 1996-07-15
ES2129293A1 (es) 1999-06-01
RS49578B (sr) 2007-04-10
AU3173095A (en) 1996-04-04
DE19534745B4 (de) 2004-06-09
NL1001196C2 (nl) 1997-04-04

Similar Documents

Publication Publication Date Title
IS1788B (is) Andestrogen benzothiophenyl efnasambönd
DK0802183T3 (da) Østrogenforbindelser
DK0777671T3 (da) Spiro-azabicykliske forbindelser
FI972970L (fi) Uusia yhdisteitä
NO971814L (no) Östrogene midler
FI960519L (fi) Uusia yhdisteitä
ID15904A (id) Senyawa-senyawa tiofenopirimidina
BR9710352A (pt) Compostos piridilpirrole
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
PT906288E (pt) Novos compostos
BR9705635A (pt) Compostos
FI950403L (fi) Neurosuojaavia yhdisteitä
DK0923594T3 (da) Bromotiacumicinforbindelser
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
NO972257D0 (no) 18-nor-vitamin D-forbindelser
IS4932A (is) Ný efnasambönd
FI971971A7 (fi) Pyridatsinokinoliiniyhdisteitä
KR950024252U (ko) 부착이 용이한 단추
SE9402813D0 (sv) New compounds
SE9402170D0 (sv) New compounds
SE9402838D0 (sv) New compounds
SE9403728D0 (sv) New compounds
SE9604788D0 (sv) New compounds
SE9600554D0 (sv) New compounds